BBCMF (Lir Life Sciences) Total Liabilities: $0.06 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Total Liabilities?

Lir Life Sciences BBCMF -80.00% 15 Total Liabilities is $0.06 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Lir Life Sciences's Total Liabilities for the quarter that ended in Jan. 2026 was $0.06 Mil.

Lir Life Sciences's quarterly Total Liabilities declined from Jul. 2025 ($0.30 Mil) to Oct. 2025 ($0.04 Mil) but then increased from Oct. 2025 ($0.04 Mil) to Jan. 2026 ($0.06 Mil).

Lir Life Sciences's annual Total Liabilities increased from . 20 ($0.00 Mil) to Apr. 2024 ($0.17 Mil) but then declined from Apr. 2024 ($0.17 Mil) to Apr. 2025 ($0.15 Mil).

Lir Life Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Total Liabilities Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Total Liabilities
0.17 0.15

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Liabilities Get a 7-Day Free Trial 0.00 0.15 0.30 0.04 0.06
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lir Life Sciences's Total Liabilities for the fiscal year that ended in Apr. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.145+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.15

Total Liabilities=Total Assets (A: Apr. 2025 )-Total Equity (A: Apr. 2025 )
=0.087--0.059
=0.15

Lir Life Sciences's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=0.057+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=0.06

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=0.829-0.773
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.06 Mil mean?
Lir Life Sciences (BBCMF) has a Total Liabilities of $0.06 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors.
Is Lir Life Sciences' Total Liabilities too high?
Lir Life Sciences' current Total Liabilities is $0.06 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Total Liabilities compare to VRTX and REGN?
Lir Life Sciences' Total Liabilities of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Lir Life Sciences and its competitors. Lir Life Sciences's current Total Liabilities is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Total Liabilities of $0.06 Mil. The current Total Liabilities is $0.06 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Total Liabilities is $0.06 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price